Biogen Canada was established in Mississauga, Ontario in April 1998 and has been conducting business in Canada for more than 15 years. The scope of our operations here has continued to expand and has helped to improve the care of individuals affected by MS and hemophilia.

We are dedicated to partnering with Health Canada, the respective provincial ministries of health, the Neurologists that specialize in the management of MS, the MS Nurse Specialists who provide care to people affected with MS, and the organizations within the communities that represent individuals who are affected by MS.

We also interact closely with our payer customers, the public and private drug plans, as well as Canada’s two blood services agencies to secure and maintain appropriate reimbursement. We strive to ensure that the appropriate Biogen product can be prescribed to the appropriate patient, at the appropriate time.